Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma
- 1 November 2006
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 66 (3) , 714-720
- https://doi.org/10.1016/j.ijrobp.2006.05.064
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy—tumor volume and FDG uptake valueGynecologic Oncology, 2006
- Prognostic Value of Tumor Volume in Nasopharyngeal CarcinomaYonsei Medical Journal, 2005
- Distribution of Cell-Free and Cell-Associated Epstein–Barr Virus (EBV) DNA in the Blood of Patients with Nasopharyngeal Carcinoma and EBV-Associated LymphomaClinical Chemistry, 2004
- Phase II Study of Neoadjuvant Carboplatin and Paclitaxel Followed by Radiotherapy and Concurrent Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: Therapeutic Monitoring With Plasma Epstein-Barr Virus DNAJournal of Clinical Oncology, 2004
- Expression of GLUT‐1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F‐18]‐fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovaryInternational Journal of Cancer, 2004
- Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography—clinical use, interpretation methods, diagnostic improvementsSeminars in Nuclear Medicine, 2003
- Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal CarcinomaJNCI Journal of the National Cancer Institute, 2002
- Molecular imaging of cancer with positron emission tomographyNature Reviews Cancer, 2002
- Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapyZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- [Fluorine-18]Fluorodeoxyglucose Positron Emission Tomography, DNA Ploidy and Growth Fraction in Squamous-Cell Carcinomas of the Head and NeckORL, 2001